Home › Gastrointestinal Cancers › Ohio › Columbus
Gastrointestinal Cancers clinical trials in Columbus, OH
4 studies for Gastrointestinal Cancers are looking for participants at sites in and around Columbus (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
RecruitingPhase 3
- GSK Investigational Site, Columbus
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RecruitingPhase 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RecruitingPhase 1/2
- The Ohio State University Wexner Medical Center, Columbus
Feasibility Study of CBCT for IGRT in Cancer Patients
Recruiting
- James Outpatient Center, Columbus
- Ohio State University, Brain and Spine Hospital, Columbus
- The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus
- and 1 more
Gastrointestinal Cancers trials in other cities
- Houston, TX21 studies
- Boston, MA15 studies
- New York City, NY12 studies
- Nashville, TN10 studies
- Los Angeles, CA9 studies
- Baltimore, MD8 studies
- Durham, NC8 studies
- Arlington, VA8 studies
- Dallas, TX8 studies
- Cincinnati, OH8 studies
- San Antonio, TX7 studies
- Aurora, CO7 studies
Other studies in Columbus
- Non-Small Cell Lung Cancer55 studies
- Cancer (all types)39 studies
- Breast Cancer39 studies
- Ovarian Cancer39 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Chronic Lymphocytic Leukemia29 studies
- Metastatic Cancer27 studies
- Endometrial Cancer26 studies
- Colorectal Cancer24 studies
- Multiple Myeloma24 studies
- Prostate Cancer24 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.